BRAF &lt;sup&gt;&lt;b&gt;V600E&lt;/b&gt;&lt;/sup&gt; Metastatic Synovial Sarcoma Treated with BRAF &amp; MEK Inhibitors Achieves Complete Response. This evidence concerns the gene MAP2K7 and sarcoma.